academic article

• Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials..  Clinical therapeutics.  37:1045-1054. 2015
• Demographic Disparities Among Medicare Beneficiaries with Type 2 Diabetes Mellitus in 2011: Diabetes Prevalence, Comorbidities, and Hypoglycemia Events..  Population health management.  :-. 2015
• Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials..  The American journal of managed care.  20:s296-s305. 2014
• Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey..  Clinical therapeutics.  36:494-506. 2014
• Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin..  The American journal of managed care.  20:s16-s24. 2014
• Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging..  BMC research notes.  7:-. 2014
• Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence..  Patient preference and adherence.  8:683-692. 2014